• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性痴呆的分类、诊断与治疗

Classification, diagnosis and treatment of vascular dementia.

作者信息

Konno S, Meyer J S, Terayama Y, Margishvili G M, Mortel K F

机构信息

Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Drugs Aging. 1997 Nov;11(5):361-73. doi: 10.2165/00002512-199711050-00004.

DOI:10.2165/00002512-199711050-00004
PMID:9359023
Abstract

Vascular dementia (VAD) is considered to be the second most common cause of dementia in Europe and the US. In Asia and many developing countries, it is more common than dementia of the Alzheimer's type (DAT). VAD is the most preventable form of dementia associated with later life. The pathogenesis of VAD is multifactorial, and it represents a heterogeneous, not a homogeneous, clinical entity. Classification of VAD by pathogenesis is important for its prevention and treatment. Control of the risk factors for VAD reduces its incidence and stabilises or improves cognitive performance following stroke. Proper diagnostic evaluation of VAD requires: (i) a well defined quantitative assessment of the cognitive deficits present; (ii) assessment of risk factors for stroke; (iii) identification of cerebral vascular lesions by history, neurological examination and neuroimaging; (iv) exclusion of other causes of dementia; (v) establishment of a positive diagnosis of possible, probable or definite VAD versus DAT or mixed VAD/DAT; and (vi) identification of the temporal relationship between cognitive deficits and cerebral vascular lesions. VAD can be subdivided into 8 major types, as follows: (i) multi-infarct dementia secondary to large cerebral emboli [type 1]; (ii) strategically placed infarctions causing dementia [type 2]; (iii) multiple subcortical lacunar lesions secondary to atherosclerosis or degenerative arteriolar changes [type 3]; (iv) Binswanger's disease (arteriosclerotic subcortical leukoencephalopathy) [type 4]; (v) mixtures of types 1, 2 and 3 [type 5]; (vi) haemorrhagic lesions causing dementia [type 6]; (vii) subcortical dementia secondary to hereditary factors (type 7); and (viii) mixtures of DAT and VAD (type 8). Treatment is dictated by the pathogenetic subtype of VAD that is present.

摘要

血管性痴呆(VAD)被认为是欧美地区第二常见的痴呆病因。在亚洲和许多发展中国家,它比阿尔茨海默病型痴呆(DAT)更为常见。VAD是与老年期相关的最可预防的痴呆形式。VAD的发病机制是多因素的,它代表的是一种异质性而非同质性的临床实体。按发病机制对VAD进行分类对其预防和治疗很重要。控制VAD的危险因素可降低其发病率,并在中风后稳定或改善认知功能。对VAD进行恰当的诊断评估需要:(i)对存在的认知缺陷进行明确的定量评估;(ii)评估中风的危险因素;(iii)通过病史、神经系统检查和神经影像学识别脑血管病变;(iv)排除其他痴呆病因;(v)确立可能、很可能或肯定的VAD与DAT或混合型VAD/DAT的阳性诊断;以及(vi)确定认知缺陷与脑血管病变之间的时间关系。VAD可细分为8种主要类型,如下:(i)继发于大脑大栓子的多梗死性痴呆[1型];(ii)导致痴呆的关键部位梗死[2型];(iii)继发于动脉粥样硬化或小动脉退行性改变的多发性皮质下腔隙性病变[3型];(iv)宾斯旺格病(动脉硬化性皮质下白质脑病)[4型];(v)1、2和3型的混合[5型];(vi)导致痴呆的出血性病变[6型];(vii)继发于遗传因素的皮质下痴呆(7型);以及(viii)DAT和VAD的混合(8型)。治疗取决于所存在的VAD致病亚型。

相似文献

1
Classification, diagnosis and treatment of vascular dementia.血管性痴呆的分类、诊断与治疗
Drugs Aging. 1997 Nov;11(5):361-73. doi: 10.2165/00002512-199711050-00004.
2
Vascular dementia: still a debatable entity?血管性痴呆:仍是一个有争议的实体?
J Neurol Sci. 1996 Nov;143(1-2):31-40. doi: 10.1016/s0022-510x(96)00191-8.
3
Diagnosis and management of vascular cognitive impairment and dementia.血管性认知障碍和痴呆的诊断与管理
J Neural Transm Suppl. 2002(63):91-109. doi: 10.1007/978-3-7091-6137-1_6.
4
Vascular dementia today.当下的血管性痴呆
Rev Neurol (Paris). 1999;155 Suppl 4:S64-72.
5
Vasodilator responses to acetazolamide tested in subtypes of vascular dementia.在血管性痴呆亚型中测试乙酰唑胺的血管舒张反应。
J Stroke Cerebrovasc Dis. 1998 Sep-Oct;7(5):323-9. doi: 10.1016/s1052-3057(98)80050-5.
6
Vascular dementia: distinguishing characteristics, treatment, and prevention.血管性痴呆:特征、治疗与预防
J Am Geriatr Soc. 2003 May;51(5 Suppl Dementia):S296-304. doi: 10.1046/j.1532-5415.5155.x.
7
Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention.
Med Clin North Am. 2002 May;86(3):477-99. doi: 10.1016/s0025-7125(02)00008-1.
8
Research criteria for subcortical vascular dementia in clinical trials.临床试验中皮质下血管性痴呆的研究标准。
J Neural Transm Suppl. 2000;59:23-30. doi: 10.1007/978-3-7091-6781-6_4.
9
Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?临床试验中血管性痴呆诊断临床标准的局限性。专注于皮质下血管性痴呆是一种解决办法吗?
Ann N Y Acad Sci. 2000 Apr;903:262-72. doi: 10.1111/j.1749-6632.2000.tb06376.x.
10
Neuropsychological aspects of vascular dementia.血管性痴呆的神经心理学方面
Brain Cogn. 1996 Jul;31(2):269-82. doi: 10.1006/brcg.1996.0045.

引用本文的文献

1
Exploring the Link between Anticoagulation, Cognitive Impairment and Dementia in Atrial Fibrillation: A Systematic Review.探索心房颤动中抗凝、认知障碍与痴呆之间的联系:一项系统综述。
J Clin Med. 2024 Apr 21;13(8):2418. doi: 10.3390/jcm13082418.
2
Hexahydrocurcumin attenuated demyelination and improved cognitive impairment in chronic cerebral hypoperfusion rats.六氢姜黄素减轻慢性脑低灌注大鼠的脱髓鞘和认知功能障碍。
Inflammopharmacology. 2024 Apr;32(2):1531-1544. doi: 10.1007/s10787-023-01406-7. Epub 2023 Dec 28.
3
The effects of CNS atrophy and ICVD on tests of executive function and functional status are mediated by intelligence.

本文引用的文献

1
Vascular dementia: Problems with nomenclature, definition, and classification.血管性痴呆:命名、定义及分类问题
J Stroke Cerebrovasc Dis. 1994;4(1):52-6. doi: 10.1016/S1052-3057(10)80147-8. Epub 2010 Jun 11.
2
Cerebral Embolism as a Cause of Stroke and Transient Ischemic Attack.
Echocardiography. 1996 Sep;13(5):513-518. doi: 10.1111/j.1540-8175.1996.tb00929.x.
3
The pharmacoeconomics of dementia therapies. Bringing the clinical, research and economic perspectives together.
Drugs Aging. 1997 Mar;10(3):219-33. doi: 10.2165/00002512-199710030-00006.
4
中枢神经系统萎缩和缺血性脑血管病对执行功能测试及功能状态的影响是由智力介导的。
Cereb Circ Cogn Behav. 2023 Sep 15;5:100184. doi: 10.1016/j.cccb.2023.100184. eCollection 2023.
4
TGF-β Signaling: A Therapeutic Target to Reinstate Regenerative Plasticity in Vascular Dementia?转化生长因子-β信号传导:恢复血管性痴呆再生可塑性的治疗靶点?
Aging Dis. 2020 Jul 23;11(4):828-850. doi: 10.14336/AD.2020.0222. eCollection 2020 Jul.
5
Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies.非维生素K拮抗剂口服抗凝剂与心房颤动患者的认知障碍:来自对90000多名患者的随机对照试验和真实世界研究的荟萃分析的见解
Front Aging Neurosci. 2018 Oct 2;10:258. doi: 10.3389/fnagi.2018.00258. eCollection 2018.
6
Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation: Protocol for a systemic review of randomized controlled trials and real-world studies.非维生素K拮抗剂口服抗凝剂用于心房颤动时的认知障碍风险:随机对照试验和真实世界研究的系统评价方案
Medicine (Baltimore). 2018 Aug;97(34):e12072. doi: 10.1097/MD.0000000000012072.
7
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?欧洲心律协会(EHRA)/心律学会(HRS)/亚太心律学会(APHRS)/拉丁美洲心律学会(LAHRS)关于心律失常与认知功能的专家共识:最佳实践是什么?
J Arrhythm. 2018 Mar 23;34(2):99-123. doi: 10.1002/joa3.12050. eCollection 2018 Apr.
8
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?欧洲心律协会(EHRA)/心律学会(HRS)/亚太心律学会(APHRS)/拉丁美洲心律学会(LAHRS)关于心律失常与认知功能的专家共识:最佳实践是什么?
Heart Rhythm. 2018 Jun;15(6):e37-e60. doi: 10.1016/j.hrthm.2018.03.005. Epub 2018 Mar 18.
9
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?欧洲心律协会(EHRA)/心律学会(HRS)/亚太心律学会(APHRS)/拉丁美洲心律学会(LAHRS)关于心律失常与认知功能的专家共识:最佳实践是什么?
Europace. 2018 Sep 1;20(9):1399-1421. doi: 10.1093/europace/euy046.
10
ST09, a Novel Thioester Derivative of Tacrine, Alleviates Cognitive Deficits and Enhances Glucose Metabolism in Vascular Dementia Rats.ST09,一种新型他克林硫酯衍生物,可减轻血管性痴呆大鼠的认知缺陷并增强其葡萄糖代谢。
CNS Neurosci Ther. 2016 Mar;22(3):220-9. doi: 10.1111/cns.12495. Epub 2016 Jan 27.
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.炎症、阿司匹林与看似健康男性的心血管疾病风险
N Engl J Med. 1997 Apr 3;336(14):973-9. doi: 10.1056/NEJM199704033361401.
5
The Canadian Study of Health and Aging: risk factors for vascular dementia.加拿大健康与老龄化研究:血管性痴呆的风险因素
Stroke. 1997 Mar;28(3):526-30. doi: 10.1161/01.str.28.3.526.
6
Status of risk factors for dementia associated with stroke.与中风相关的痴呆症危险因素状况。
Stroke. 1997 Feb;28(2):459-63. doi: 10.1161/01.str.28.2.459.
7
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.基于人群的研究中的心房颤动与痴呆。鹿特丹研究。
Stroke. 1997 Feb;28(2):316-21. doi: 10.1161/01.str.28.2.316.
8
Presence and treatment of vascular risk factors in patients with vascular cognitive impairment.血管性认知障碍患者血管危险因素的存在情况及治疗
Arch Neurol. 1997 Jan;54(1):33-9. doi: 10.1001/archneur.1997.00550130019010.
9
Vascular dementia: still a debatable entity?血管性痴呆:仍是一个有争议的实体?
J Neurol Sci. 1996 Nov;143(1-2):31-40. doi: 10.1016/s0022-510x(96)00191-8.
10
Vascular dementia: a construct in evolution.
Cerebrovasc Brain Metab Rev. 1996 Winter;8(4):296-325.